Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invivo Therapeutics Holdings Corp (NVIV)

Invivo Therapeutics Holdings Corp (NVIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,306
  • Shares Outstanding, K 9,312
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,420 K
  • 60-Month Beta 1.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.52
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.70
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/27/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -7.48
  • Growth Rate Est. (year over year) +13,455.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.52 +8.88%
on 07/24/19
0.86 -33.72%
on 07/31/19
-0.02 (-3.32%)
since 07/23/19
3-Month
0.52 +8.88%
on 07/24/19
1.37 -58.39%
on 05/29/19
-0.55 (-49.11%)
since 05/23/19
52-Week
0.52 +8.88%
on 07/24/19
2.75 -79.27%
on 10/22/18
-1.45 (-71.78%)
since 08/23/18

Most Recent Stories

More News
InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the publication of a manuscript in the peer-reviewed journal Spinal Cord describing its CONTEMPO registry study data. The CONTEMPO registry...

NVIV : 0.57 (unch)
InVivo Therapeutics Announces Postponement of Annual Meeting

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that it has postponed its 2019 annual meeting of stockholders. The annual meeting, which was originally scheduled for June 11, 2019, had...

NVIV : 0.57 (unch)
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury

InVivo Therapeutics Holdings Corp. (NVIV) today announced that the first two patients have been enrolled into The INSPIRE 2.0 Study (InVivo Study of Probable Benefit of the Neuro-Spinal ...

NVIV : 0.57 (unch)
Research Report Identifies 1-800 FLOWERS.COM, Ceragon Networks, Tremont Mortgage Trust, Golden Minerals, GEE Group, and InVivo Therapeutics with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of 1-800 FLOWERS.COM, Inc....

NVIV : 0.57 (unch)
FLWS : 15.29 (-10.38%)
TRMT : 4.48 (-1.97%)
CRNT : 2.28 (-3.80%)
AUMN : 0.26 (+4.00%)
JOB : 0.51 (-6.39%)
InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold(TM) in Acute Thoracic Complete Spinal Cord Injury

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) ("InVivo" or the "Company") today announced the presentation of the twelve-month results from the company's single-arm INSPIRE study (InVivo...

NVIV : 0.57 (unch)
InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update

InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the year ended December 31, 2018.

NVIV : 0.57 (unch)
InVivo Therapeutics Announces Appointment of Richard Christopher as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

InVivo Therapeutics Holdings Corp. (Nasdaq:NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries (SCIs), today announces...

NVIV : 0.57 (unch)
ICAD : 5.98 (-3.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade NVIV with:

Business Summary

InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible...

See More

Key Turning Points

2nd Resistance Point 0.58
1st Resistance Point 0.57
Last Price 0.57
1st Support Level 0.56
2nd Support Level 0.56

See More

52-Week High 2.75
Fibonacci 61.8% 1.90
Fibonacci 50% 1.64
Fibonacci 38.2% 1.37
Last Price 0.57
52-Week Low 0.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar